Financial statements Bioprofit
Balance sheet data of BIOPROFIT
Year
|
2022
|
2023
|
---|---|---|
Total assets | 1 875 175,38 | 1 627 791,50 |
A. Fixed assets | 675 862,82 | 624 883,62 |
B. Current assets | 1 199 312,56 | 1 002 907,88 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 |
Total liabilities | 1 875 175,38 | 1 627 791,50 |
A. Equity | 1 327 653,80 | 1 185 129,38 |
B. Liabilities and provisions for liabilities | 547 521,58 | 442 662,12 |
I. Long-term liabilities | 93 117,34 | 95 817,34 |
II. Short-term liabilities | 454 404,24 | 346 844,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.